V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007868 | 190005947 | 0 | 42.6 | Neo-adjuvant (N) | 2019-02-18 | 2019-03-10 | EW EuroEwing 2012 Arm B VC | 02 | Y | DACARBAZINE | 101667864 |
| 190007887 | 190005948 | null | 53.5 | Neo-adjuvant (N) | 2017-04-04 | 2017-05-08 | Cisplatin | 02 | N | CISPLATIN | 100553113 |
| 190007891 | 190005949 | 0 | 68.4 | Palliative (P) | 2018-08-08 | 2018-08-26 | Etoposide + Ifosfamide + HD Mtx | 01 | null | CARBOPLATIN + FLUOROURACIL | 101622902 |
| 190007900 | 190005950 | 1.75 | null | Curative (C) | null | 2018-11-03 | Cisplatin | null | null | CISPLATIN | 101088727 |
| 190007908 | 190005951 | 0 | 60.8 | Palliative (P) | 2020-07-26 | 2020-07-31 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | null | FLUOROURACIL + IRINOTECAN | 101778573 |
| 190007914 | 190005952 | 1.68 | 97 | Neo-adjuvant (N) | 2016-05-25 | 2016-06-10 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100957670 |
| 190007921 | 190005953 | 0 | 54.3 | null | 2019-06-12 | 2019-07-02 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | CISPLATIN + RT | 100408763 |
| 190007926 | 190005954 | 1.67 | 48.4 | Curative (C) | 2019-09-25 | 2019-11-22 | DOXORUBICIN + METHOTREXATE + MIFAMURTIDE | 02 | N | TRIAL UNSPECIFIED | 101129410 |
| 190007940 | 190005955 | 0 | 38.7 | Palliative (P) | 2017-04-14 | 2017-08-07 | GemCarbo Days 1+8 | 01 | N | CISPLATIN + RT | 100396252 |
| 190007941 | 190005956 | 0 | 37.4 | Curative (C) | 2020-09-27 | 2021-03-24 | EW EuroEwing 99 : VActI | 02 | N | FULVESTRANT + RIBOCICLIB | 100353331 |
| 190007946 | 190005957 | 1.75 | 65 | Palliative (P) | 2020-09-12 | 2020-09-13 | CYTARABINE + FLUDARABINE | 02 | null | ENZALUTAMIDE | 101263361 |
| 190007951 | 190005958 | 0 | 69.3 | Curative (C) | 2020-11-11 | 2020-11-19 | CNS HGG Temozolomide maintenance | 02 | N | ATEZOLIZUMAB | 100006144 |
| 190007959 | 190005959 | 1.78 | 115 | Disease modification (D) | 2017-06-22 | 2017-07-21 | EURAMOS TRIAL | 02 | N | FLUOROURACIL + OXALIPLATIN | 100937043 |
| 190007960 | 190005960 | 1.8 | 96.5 | Adjuvant (A) | 2019-01-07 | 2019-01-15 | VINCRISTINE | 02 | N | TRIAL UNSPECIFIED | 101631786 |
| 190007962 | 190005961 | 1.79 | 62 | 03 | 2017-11-11 | 2017-11-16 | TEMOZOLOMIDE | 02 | N | PACLITAXEL | 101116804 |
| 190007975 | 190005962 | 1.51 | null | Palliative (P) | 2018-04-23 | 2018-05-08 | Cyclophosphamide + Topotecan | 02 | Y | CISPLATIN + FLUOROURACIL | 100532757 |
| 190007982 | 190005963 | 1.93 | 59.7 | null | 2019-02-03 | 2019-02-03 | Cisplatin 7 day | N | N | CISPLATIN | 100965767 |
| 190007985 | 190005964 | null | 88.35 | null | null | 2017-02-06 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100952773 |
| 190007991 | 190005965 | 0 | 44.9 | Neo-adjuvant (N) | null | 2019-01-22 | Capecitabine (14 days)+Carboplatin | null | null | CVD | 100804907 |
| 190007993 | 190005966 | 1.63 | 76 | Palliative (P) | 2017-03-13 | 2017-03-20 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100526904 |
| 190007995 | 190005967 | 1.8 | 56 | Palliative (P) | 2017-01-19 | 2017-01-27 | Carboplatin 21day + Paclitaxel 7day | Y | N | CARBOPLATIN + PACLITAXEL | 100721617 |
| 190008005 | 190005968 | 1.82 | 58 | Neo-adjuvant (N) | 2018-07-19 | 2018-09-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | CISPLATIN + GEMCITABINE + IFOSFAMIDE + PACLITAXEL | 100408957 |
| 190008008 | 190005969 | 1.77 | 84.7 | Palliative (P) | 2016-03-06 | 2016-07-30 | PACLITAXEL | 02 | null | CISPLATIN + GEMCITABINE | 100549007 |
| 190008029 | 190005970 | 1.84 | 59.5 | null | 2017-11-23 | 2018-05-04 | Cyclophosphamide + Topotecan | 02 | N | CARBOPLATIN + ETOPOSIDE | 100040443 |
| 190008042 | 190005971 | 1.66 | 65.5 | null | null | 2018-04-26 | CARBOPLATIN + PACLITAXEL | N | null | CARBOPLATIN + PACLITAXEL | 101259588 |
| 190008048 | 190005972 | 1.57 | 55.4 | Neo-adjuvant (N) | 2021-03-13 | 2021-03-13 | Liposomal Doxorubicin 50mg/m2 | 02 | N | TRIAL UNSPECIFIED | 101836772 |
| 190008053 | 190005973 | 0 | 63.4 | null | 2019-01-17 | 2019-08-14 | null | 02 | null | FLUOROURACIL + OXALIPLATIN | 100049858 |
| 190008059 | 190005974 | 1.84 | 74 | null | 2021-07-15 | 2022-02-19 | EURAMOS TRIAL | null | null | CARBOPLATIN + GEMCITABINE | 101539614 |
| 190008062 | 190005975 | 1.89 | 38.2 | Curative (C) | 2019-08-13 | 2019-08-13 | CARBOPLATIN + PACLITAXEL | 2 | N | CARBOPLATIN + PACLITAXEL | 100509524 |
| 190008067 | 190005976 | 1.82 | 53.2 | Palliative (P) | 2017-06-23 | 2017-12-13 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100253779 |
| 190008069 | 190005977 | 1.56 | 98.1 | Curative (C) | 2020-05-04 | 2020-06-06 | EDP | 02 | N | IPILIMUMAB + NIVOLUMAB | 100075619 |
| 190008079 | 190005979 | 1.75 | null | Adjuvant (A) | 2020-05-12 | 2020-05-13 | Etoposide oral | 02 | null | CISPLATIN + DOCETAXEL | 101186131 |
| 190008082 | 190005980 | 1.71 | 86.6 | null | 2019-07-02 | 2019-12-25 | NIVOLUMAB | 02 | N | LANREOTIDE | 101487489 |
| 190008095 | 190005981 | 0 | 42.5 | Palliative (P) | 2019-01-17 | 2019-01-18 | Dacarbazine | 02 | null | CAPECITABINE + OXALIPLATIN | 101435488 |
| 190008101 | 190005982 | null | 63.7 | null | 2018-10-05 | 2019-04-18 | Capecitabine (14 days)+Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100415829 |
| 190008110 | 190005983 | 1.8 | 59.3 | null | 2018-04-11 | 2018-04-20 | VAI (Ifos 3g/m2) | 01 | null | CAPECITABINE | 100257695 |
| 190008131 | 190005984 | 1.69 | 55.8 | Curative (C) | 2018-03-13 | 2018-09-30 | Etoposide oral | 01 | N | FLUOROURACIL + IRINOTECAN | 100286973 |
| 190008135 | 190005985 | 1.79 | 54.2 | Palliative (P) | 2020-12-05 | 2020-12-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100764551 |
| 190008141 | 190005986 | 1.81 | 72.1 | 03 | 2018-11-08 | 2018-11-27 | Irinotecan + Modified De Gramont | 02 | N | TRIAL UNSPECIFIED | 100420955 |
| 190008146 | 190005987 | 1.75 | null | Palliative (P) | 2018-03-22 | 2018-06-30 | EW Rel rEECur Gemcitabine/Docetaxel + GCSF | 02 | N | TRASTUZUMAB | 101233068 |
| 190008148 | 190005988 | 1.67 | 94.3 | Curative (C) | 2020-02-25 | 2020-03-05 | Etoposide + Ifosfamide + HD Mtx | 01 | null | CAPECITABINE + OXALIPLATIN | 100640897 |
| 190008159 | 190005989 | 1.62 | 52.3 | Palliative (P) | 2020-01-05 | 2020-01-19 | EW EuroEwing 2012 Arm B VC | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101102286 |
| 190008170 | 190005990 | null | 96.5 | null | 2017-11-23 | 2017-12-22 | NIVOLUMAB | N | Y | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101093495 |
| 190008179 | 190005991 | 1.9 | 62 | Curative (C) | 2019-10-28 | 2019-12-22 | Trial Unspecified | 02 | N | CETUXIMAB + RT | 101220439 |
| 190008184 | 190005992 | 1.91 | 50.3 | Palliative (P) | 2011-08-17 | 2016-08-31 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100306595 |
| 190008187 | 190005993 | null | 26.5 | Palliative (P) | 2017-12-09 | 2017-12-09 | VAI (Ifos 3g/m2) | 01 | N | CAPECITABINE + IRINOTECAN | 100655437 |
| 190008188 | 190005994 | 1.65 | 57.4 | null | 2019-05-15 | 2019-06-26 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100477306 |
| 190008208 | 190005995 | 1.84 | 64 | 02 | 2018-01-20 | 2018-01-20 | EW EuroEwing 2012 Arm B VDC/IE | 02 | N | ECX | 101616902 |
| 190008209 | 190005996 | 1.67 | null | Curative (C) | 2016-11-15 | 2016-12-31 | Cisplatin 7 day | N | N | CISPLATIN | 100067138 |
| 190008214 | 190005997 | 1.82 | 52.7 | Adjuvant (A) | 2018-09-03 | 2019-03-02 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | PEMBROLIZUMAB | 101290738 |